Vanderbilt researchers have identified a new target for blocking breast cancer metastasis.

Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis.

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation.

Charlie Haller had never smoked or used chewing tobacco and wasn’t a heavy drinker, so the 41-year-old Lyles, Tennessee, man wasn’t thinking about cancer when a mass developed on the side of his neck.

The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics.